Pharmacogenomics and Cardiovascular Disease, Pharmacogenomics of Warfarin
Pharmacogenetics and cardiovascular disease
Impact on drug response and applications to disease management.
http://www.medscape.com/viewarticle/440225
(Subscription to Medscape required)
Pharmacogenetics and the treatment of cardiovascular disease
http://heart.bmj.com/cgi/content/extract/84/4/353
FDA Approves Updated Warfarin (Coumadin) Prescribing Information
New Genetic Information May Help Providers Improve Initial Dosing Estimates of the Anticoagulant for Individual Patients 8/16/2007
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108967.htm
Pharmacogenomics: Using Genetic Testing to Guide Warfarin Therapy
http://www.ncbi.nlm.nih.gov/pubmed/16960144
CME Education Program on Warfarin PGx from ARUP Labs
http://arup.cnpg.com/med/webinar/flockhartmcmillin/20060829/
From the University of North Carolina
http://www.med.unc.edu/medicine/web/10.29.07%20Coumadin%20PGx%20Jonas.ppt (Powerpoint)
Science
- The PMC Clinical Science Committee
- General Personalized Medicine
- Drug Interactions (Toxicology)
- General Genomics
- Personal Genomics
- Personalized Disease Management
- Pharmacogenomics/ Pharmacogenetics
- PGx and Cancer
- PGx in Pain Management
- Pharmacogenomics and Cardiovascular Disease, Pharmacogenomics of Warfarin
- Pharmacogenomics and Diabetes




ShareThis